Skip to main content
. 2017 Oct 7;8(55):94920–94931. doi: 10.18632/oncotarget.21659

Table 4. Subgroup analysis of the form of PERT and the sample size.

Method Subgroup Study WMD (95% CI) Z P Heterogeneity
P I2 Tau2
CFA Form Standardization 5 17.86 (13.83, 21.89) 8.68 0.000 0.148 41.1% 7.880
Non-standardization 2 15.53 (–7.20, 38.25) 1.34 0.181 0.000 94.3% 253.850
Sample < 50 4 16.80 (8.42, 25.19) 3.93 0.000 0.000 83.9% 53.870
> 50 3 19.06 (10.75, 27.37) 4.50 0.000 0.052 66.2% 34.501